Goldman Sachs on Dynavax Technologies (DVAX): 'we look for clarity on possible strategic interest in the program'
Tweet Send to a Friend
Goldman Sachs analyst Paul Choi reiterated a Sell rating and $11.00 price target on Dynavax Technologies (NASDAQ: DVAX).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
